Binding affinity of surface functionalized gold nanoparticles to hydroxyapatite

Journal of Biomedical Materials Research - Part A

Volumn 99 A, Issue 1, 2011, Pages 58-66

  Ross, Ryan D ^a   Roeder, Ryan K ^a  

^a University of Notre Dame   (United States)

Author keywords

binding affinity; bisphosphonate; contrast agent; gold nanoparticles; hydroxyapatite; targeted delivery

Indexed keywords

BINDING AFFINITIES; BISPHOSPHONATES; CONTRAST AGENT; GOLD NANOPARTICLES; TARGETED DELIVERY;

AMINO ACIDS; APATITE; BINDING ENERGY; BONE; CARBOXYLATION; DRUG THERAPY; EQUILIBRIUM CONSTANTS; FUNCTIONAL GROUPS; GENE THERAPY; GENE TRANSFER; GOLD ALLOYS; HYDROXYAPATITE; IONIZATION; MEDICAL APPLICATIONS; NANOPARTICLES; TISSUE;

GOLD;

2 AMINOETHYLPHOSPHONIC ACID; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARBOXYLIC ACID; GLUTAMIC ACID; GOLD NANOPARTICLE; HYDROXYAPATITE; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; BINDING AFFINITY; BONE MINERAL; CRYSTAL; DRUG BINDING; DRUG SYNTHESIS; DRUG TARGETING; PARTICLE SIZE; SERUM;

ALENDRONATE; AMINOETHYLPHOSPHONIC ACID; ANIMALS; CALCIUM; CATTLE; DURAPATITE; GLUTAMIC ACID; GOLD; METAL NANOPARTICLES; SERUM;

EID: 80051890879     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33165     Document Type: Article

References (54)

1. Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ,. Biological applications of gold nanoparticles. Chem Soc Rev 2008; 37: 1896-1908.
2. Huang X, Jain PK, El-Sayed IH, El-Sayed MA,. Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine 2007; 2: 681-693. (Pubitemid 350268247)
3. Ghosh P, Han G, De M, Kim CK, Rotello VM,. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008; 60: 1307-1315.
4. Pissuwan D, Valenzuela SM, Cortie MB,. Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotechnol 2006; 24: 62-67. (Pubitemid 43151977)
5. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL,. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Nat Acad Sci 2003; 100: 13540-13554.
6. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA,. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 1997; 277: 1078-1081. (Pubitemid 27371624)
7. Möller R, Fritzche W,. Metal nanoparticle-based detection for DNA analysis. Curr Pharm Biotechnol 2007; 8: 274-285. (Pubitemid 47595836)
8. Hayat MA, editor. Colloidal Gold: Principles Methods and Applications, Vol. 1. San Diego: Academic Press; 1989.
9. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM,. Gold nanoparticles: A new X-ray contrast agent. Br J Radiol 2006; 79: 248-253.
10. Cai Q-Y, Kim SH, Choi KS, Kim SY, Byun SJ, Kim KW, Park SH, Juhng SK, Yoon KH,. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest Radiol 2007; 42: 797-806. (Pubitemid 350126561)
11. Kim D, Park S, Lee JH, Jeong YY, Jon S,. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 2007; 129: 7661-7665. (Pubitemid 46981930)
12. Zhang Z, Ross RD, Roeder RK,. Preparation of functionalized gold nanoparticles as a targeted X-ray contrast agent for damaged bone tissue. Nanoscale 2010; 2: 582-586.
13. Burr DB, Forwood MR, Fyhrie DP, Martin RB, Schaffler MB, Turner CH,. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res 1997; 12: 6-15. (Pubitemid 27053606)
14. Chapurlat BD, Delmas PD,. Bone microdamage: A clinical perspective. Osteoporos Int 2009; 20: 1299-1308.
15. Lee TC, Mohsin S, Taylor D, Parkesh R, Gunnlaugsson T, O'Brien FJ, Giehl M, Gowin W,. Detecting microdamage in bone. J Anat 2003; 203: 161-172. (Pubitemid 36974661)
16. Frost HM,. Presence of microscopic cracks in vivo in bone. Henry Ford Hosp Med Bull 1960; 8: 25-35.
17. Burr DB, Hooser M,. Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo. Bone 1995; 17 (4): 431-433.
18. O'Brien FJ, Taylor D, Lee TC,. An improved labelling technique for monitoring microcrack growth in compact bone. J Biomech 2002; 35: 523-526. (Pubitemid 34273645)
19. O'Brien FJ, Taylor D, Lee TC,. Microcrack accumulation at different intervals during fatigue testing of compact bone. J Biomech 2003; 36: 973-980. (Pubitemid 36566636)
20. Wang X, Niebur GL,. Microdamage propagation in trabecular bone due to changes in loading mode. J Biomech 2006; 39: 781-790. (Pubitemid 43243766)
21. Parkesh R, Mohsin S, Lee TC, Gunnlaugsson T,. Histological, spectroscopic, and surface analysis of microdamage in bone: Toward real-time analysis using fluorescent sensors. Chem Mater 2007; 19: 1656-1663. (Pubitemid 46608203)
22. Parkesh R, Lee TC, Gunnlaugsson T,. Fluorescence imaging of bone cracks (microdamage) using visibly emitting 1,8-naphthalimide-based PET sensors. Tetrahedron Lett 2009; 50: 4114-4116.
23. Mohsin S, O'Brien FJ, Lee TC,. Microcracks in compact bone: A three-dimensional view. J Anat 2006; 209: 119-124. (Pubitemid 44308888)
24. Bigley RF, Singh M, Hernandez CJ, Kazakia GJ, Martin RB, Keaveny TM,. Validity of serial milling-based imaging system for microdamage quantification. Bone 2008; 42: 212-216.
25. Zioupos P, Currey JD,. The extent of microcracking and the morphology of microcracks in damaged bone. J Mater Sci 1994; 29: 978-986.
26. O'Brien FJ, Taylor D, Dickson GR, Lee TC,. Visualization of three-dimensional microcracks in compact bone. J Anat 2000; 197: 413-420.
27. Wang X, Masse DB, Leng H, Hess KP, Ross RD, Roeder RK, Niebur GL,. Detection of trabecular bone microdamage by micro-computed tomography. J Biomech 2007; 40: 3397-3403. (Pubitemid 47632596)
28. Leng H, Wang X, Ross RD, Niebur GL, Roeder RK,. Micro-computed tomography of fatigue microdamage in cortical bone using a barium sulfate contrast agent. J Mech Behav Biomed Mater 2008; 1: 68-75. (Pubitemid 47557532)
29. Landrigan MD, Li J, Turnbull TL, Burr DB, Niebur GL, Roeder RK,. Contrast-enhanced micro-computed tomography of fatigue microdamage accumulation in human cortical bone. Bone 2011; 48: 443-450.
30. Parkesh R, Gowin W, Lee TC, Gunnlaugsson T,. Synthesis and evaluation of potential CT (computer tomography) contrast agents for bone structure and microdamage analysis. Org Biomol Chem 2006; 4: 3611-3617. (Pubitemid 44439881)
31. Parkesh R, Lee TC, Gunnlaugsson T, Gowin W,. Microdamage in bone: Surface analysis and radiological detection. J Biomech 2006; 39: 1552-1556.
32. Hubbell JH, Seltzer SM,. Table of X-ray Mass Attenuation Coefficients and Mass Energy-Absorption Coefficients (version 1.4). Gaithersburg, MD: National Institute of Standards and Technology; 2004. Available at.
33. Giersig M, Mulvaney P,. Preparation of ordered colloid monolayers by electrophoretic deposition. Langmuir 1993; 9: 3408-3413.
34. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman R,. Synthesis of thiol-derivated gold nanoparticles in a 2-phase liquid-liquid system. J Chem Soc Chem Commun 1994; 7: 801-802.
35. Brust M, Fink J, Bethell D, Schiffrin DJ, Kiely C,. Synthesis and reactions of functionalised gold nanoparticles. J Chem Soc Chem Commun 1995: 1655-1656.
36. Leff DV, Brandt L, Heath JR,. Synthesis and characterization of hydrophobic, organically-soluble gold nanocrystals functionalized with primary amines. Langmuir 1996; 12: 4723-2730.
37. Kumar A, Mandal S, Selvakannan PR, Pasricha R, Mandale AB, Sastry M,. Investigation into the interaction between surface-bound alkylamines and gold nanoparticles. Langmuir 2003; 19: 6277-6282.
38. Selvakannan PR, Mandal S, Phadtare S, Pasricha R, Sastry M,. Capping of gold Nanoparticles by the amino acid lysine renders them water-dispersable. Langmuir 2003; 19: 3545-3549.
39. Aslam M, Fu L, Su M, Vijayamohanan K, Dravid VP,. Novel one-step synthesis of amine-stabilized aqueous colloidal gold nanoparticles. J Mater Chem 2004: 1795-1997.
40. Bolander ME, Young MF, Fisher LW, Yamada Y, Termine JD,. Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid). Proc Natl Acad Sci 1988; 85: 2919-2923.
41. Fujisawa R, Wada Y, Nodasaka Y, Kuboki Y,. Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim Biophys Acta 1996; 1292: 53-60. (Pubitemid 26015424)
42. Uludag H, Kousinioris N, Gao T, Kantoci D,. Bisphosphonate conjugation to proteins as a means to impart bone affinity. Biotechnol Prog 2000; 16: 258-267. (Pubitemid 30228655)
43. Bansal G, Wright JEI, Zhang S, Zernicke RF, Uludag H,. Imparting mineral affinity to proteins with thiol-labile disulfide linkages. J Biomed Mater Res A 2005; 74: 618-628. (Pubitemid 41216264)
44. Wright JEI, Gittens SA, Bansal G, Kitov PI, Sindrey D, Kucharski C, Uludag H,. A comparison of mineral affinity of bisphosphonate-protein conjugates constructed with disulfide and thioether linkages. Biomaterials 2006; 26: 769-784. (Pubitemid 41483828)
45. Turkevich J, Stevenson PC, Hillier J,. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951; 11: 55-75.
46. Roeder RK, Converse GL, Leng H, Yue W,. Kinetic effects on hydroxyapatite whiskers synthesized by the chelate decomposition method. J Am Ceram Soc 2006; 89: 2096-2104. (Pubitemid 43941532)
47. Fiurasek P, Reven L,. Phosphonic and sulfonic acid-functionalized gold nanoparticles: A solid-state NMR study. Langmuir 2007; 23: 2857-2866. (Pubitemid 46383710)
48. Choi SW, Kim JH,. Design of surface-modified poly(D, L -lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007; 122: 24-30.
49. Wang D, Miller S, Sima M, Kopecková P, Kopecek J,. Synthesis and evaluation of water-soluble polymeric bone-targeting drug delivery systems. Bioconjug Chem 2003; 14: 853-859. (Pubitemid 37157997)
50. Murphy MB, Hartgerink JD, Goepferich A, Mikos AG,. Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties. Biomacromolecules 2007; 8: 2237-2243. (Pubitemid 47104309)
51. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD,. Cellular uptake and cytotoxicity of gold nanorods: Molecular origin of cytotoxicity and surface effects. Small 2009; 5: 701-708.
52. Ross RD, Roeder RK,. Functionalized gold nanoparticles for targeted labeling of damaged bone tissue in X-ray tomography. Trans Orthop Res Soc 2010; 35: 1368.
53. Price PA, Otsuka AS, Poser JW, Kristaponis J, Raman N,. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci USA 1976; 73: 1447-1451.
54. Reszka AA, Roda GA,. Bisphosphonate mechanism of action. Curr Rheumatol Rep 2003; 5: 65-74.